Sinovac increases vaccine production to ensure global supply

Xinhua
21 Jan 2021, 21:55 GMT+10

BEIJING, Jan. 21 (Xinhua) -- Chinese pharmaceutical company Sinovac Biotech Ltd. is ramping up the production of CoronaVac, an inactivated COVID-19 vaccine, to ensure global supply, according to Yin Weidong, chairman and CEO of the company.

"Sinovac has received vaccine orders from Brazil, Indonesia, Turkey, Chile and other countries and regions, and we are making every effort to expand the production capacity," said Yin in an interview with Xinhua News Agency. "We hope the vaccine will protect more people around the world."

The Sinovac vaccine has been approved for emergency use in several countries, including China, Indonesia, Brazil and Chile, according to Yin.

Yin added that the company has constructed a second production line, which will start operation in February, increasing its annual production capacity to 1 billion doses.

Sinovac will export semi-finished jabs to some countries, and help build local filling and packaging lines in importing countries to improve the production capacity and efficiency, Yin said.

"On the basis of an annual output of 1 billion doses, we will continue to expand production capacity. We are facing uncertainties related to the coronavirus pandemic and demand for vaccines, which shall not be responded with the usual demand-supply business model alone. Vaccines are public goods and we should shoulder social responsibilities," Yin said.

Watch latest videos

News RELEASES

Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to China National News.

More Information

26 ℃

Light Rain Shower in Shanghai/Hongqiao

International

Section

Air pollution from western U.S. state fires seen in east coast cities

PORTLAND, Oregon: Wildfires across the United States and Canada, including Oregon's "monster" two-week-old Bootleg blaze, caused harmful air pollution as ...